This cross-sectional study examined the proportion of US adults whose LDL-C levels exceed the 2026 dyslipidemia guideline targets, stratified by cardiovascular risk category and among those with established atherosclerotic cardiovascular disease (ASCVD).
The full text was not accessible — only the abstract and metadata were available, so specific results, sample sizes, and methods could not be verified or extracted.
